XML 22 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities      
Net loss for the year $ (11,125) $ (10,210) $ (10,107)
Adjustments to reconcile net loss to net cash used in operating activities:      
Depreciation 16 22 21
Share based compensation 2,140 557 1,537
Revaluation of liability with respect to warrants (46) (2,191)
Financing expenses, net (46) 323 473
Changes in assets and liabilities:      
Decrease in operating right of use asset 84 78 74
Decrease in operating lease liability (73) (69) (69)
Decrease (increase) in other current assets 424 (753) 19
Increase (decrease) in trade payables (361) (299) 961
Increase in other payables 1,270 262 928
Net cash used in operating activities (7,671) (10,135) (8,354)
Cash flows from investing activities      
Purchase of property and equipment (8) (3) (29)
Redemption of (investment in) short-term deposits 3,500
Redemption of (investment in) restricted deposit, net 4 (3)
Net cash provided by (used in) investing activities (8) 1 3,468
Cash flows from financing activities      
Exercise of warrants and options 22 5
Issuance of shares, warrants and pre-funded warrants 4,531 11,304 4,334
Issuance costs (121) (391) (364)
Net cash provided by financing activities 4,432 10,913 3,975
Effects of exchange rate changes on cash and cash equivalents 35 (41) 8
Increase (decrease) in cash and cash equivalents (3,212) 738 (903)
Cash and cash equivalents as of the beginning of the year 3,378 2,640 3,543
Cash and cash equivalents as of the end of the year 166 3,378 2,640
Non-cash investing and financing activities:      
Reclassification of warrants into equity 1,366
Bonus accrual reclassification to equity (See Note 13) 1,434
Conversion of liability into shares 410
Recognition of right of use assets 170
Supplemental disclosure of cash flow information:      
Interest received $ 13 $ 2 $ 179